Analysis reveals high mortality rates in ovarian cancer due to limited access in women from LMICs, highlighting urgent intervention needs.
(Abstracted from Int J Gynaecol Obstet 2025, doi: 10.1002/ijgo.70033) Ovarian cancer is the eighth most common cancer globally in women, and the annual incidence is 324,000 cases; annual cases are on the rise, with a predicted increase of 55% by 2050. The highest disease burden for ovarian cancer rests on women in low- and middle-income countries (LMICs), where mortality rates are high and access to care is limited.
No takes yet. Share an insight, caveat, or question.
Varghese et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: